3 unchanged sentences
Description of Document
−Removed: Amendment No.
−Removed: 1 to Exclusive License Agreement, by and between Assembly Biosciences, Inc.
−Removed: and the Indiana University Research and Technology Corporation.
−Removed: Amendment No.
−Removed: 2 to Exclusive License Agreement by and between Assembly Biosciences, Inc.
−Removed: and the Indiana University Research and Technology Corporation.
−Removed: Collaboration Agreement, dated as of July 17, 2020, by and between Assembly Biosciences, Inc.
−Removed: and BeiGene, Ltd.
+Added: Amended and Restated Bylaws of Assembly Biosciences, Inc, effective January 22, 2021.
+Added: Assembly Biosciences, Inc.
+Added: 2021 Corporate Bonus Plan.
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
8 unchanged sentences
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).
−Removed: The schedules to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
−Removed: Portions of this exhibit that are both not material and would likely cause competitive harm to the registrant if publicly disclosed have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
+Added: Represents management contracts or compensatory plans or arrangements.
The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of Assembly Biosciences, Inc.
under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
−Removed: In accordance with the requirements of the Securities Exchange Act of 1934, the registrant c aused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
+Added: In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Assembly Biosciences, Inc.
−Removed: November 5, 2020
McHutchison, A.O., M.D.
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 5, 2020
/s/ Thomas J.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.